Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
57.3M
-
Shares change
-
+3.22M
-
Total reported value, excl. options
-
$2.27B
-
Value change
-
+$131M
-
Number of buys
-
69
-
Number of sells
-
-32
-
Price
-
$39.59
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2020
125 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q4 2020.
Revolution Medicines, Inc. - Common Stock (RVMD) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.3M shares
of 186M outstanding shares and own 30.8% of the company stock.
Largest 10 shareholders include FMR LLC (9.34M shares), TRV GP III, LLC (7.02M shares), VANGUARD GROUP INC (4.04M shares), Column Group LLC (3.58M shares), BlackRock Inc. (3.51M shares), BOXER CAPITAL, LLC (3.31M shares), BVF INC/IL (2.77M shares), Cormorant Asset Management, LP (2.5M shares), TRV GP II, LLC (1.91M shares), and STATE STREET CORP (1.79M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.